Detalhe da pesquisa
1.
Hidden estrogen production from ovarian remnants leading to progression of disease in metastatic breast cancer.
Breast J
; 24(4): 642-643, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29357201
2.
A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer.
Clin Cancer Res
; 14(23): 7878-83, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19047117
3.
A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer.
Clin Breast Cancer
; 16(2): 87-94, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26454612
4.
A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane.
Clin Breast Cancer
; 6(1): 55-60, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15899073
5.
Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments.
Clin Cancer Res
; 10(12 Pt 1): 4062-7, 2004 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15217939
6.
Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer.
Clin Cancer Res
; 10(17): 5754-61, 2004 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15355903
7.
Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients.
J Clin Oncol
; 25(35): 5584-90, 2007 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-18065731
8.
Use of antioxidants during chemotherapy and radiotherapy should be avoided.
CA Cancer J Clin
; 55(5): 319-21, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16166076